Media-OutReach Newswire M&L Healthcare's First MedTech Investment Receives FDA Approval Following Successful US Trials
2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies 2.